Efficacy News and Research

RSS
Pfizer pleads guilty of defrauding Medicare, Medicaid and other government-funded health care programs

Pfizer pleads guilty of defrauding Medicare, Medicaid and other government-funded health care programs

IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites

IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites

ODAC calls for randomized study of Vion's Onrigin injection for treatment of the elderly AML patients

ODAC calls for randomized study of Vion's Onrigin injection for treatment of the elderly AML patients

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

CORD I phase III clinical trial results of XIAFLEX published

CORD I phase III clinical trial results of XIAFLEX published

Clinical trial results of sumatriptan published in a journal

Clinical trial results of sumatriptan published in a journal

Millennium's sNDA to be reviewed by the FDA

Millennium's sNDA to be reviewed by the FDA

Gene-Eden antiviral supplement may offer protection against swine flu

Gene-Eden antiviral supplement may offer protection against swine flu

Algeta partners with Bayer for development and commercialization of Alpharadin drug

Algeta partners with Bayer for development and commercialization of Alpharadin drug

Interim Phase II data of Cotara reveals signs of efficacy in GBM patients

Interim Phase II data of Cotara reveals signs of efficacy in GBM patients

FDA's Oncologic Drugs Advisory Committee votes in favor of FOLOTYN NDA

FDA's Oncologic Drugs Advisory Committee votes in favor of FOLOTYN NDA

Obama urges Americans to take precautions to protect themselves from H1N1

Obama urges Americans to take precautions to protect themselves from H1N1

More youngsters are using anti-obesity drugs

More youngsters are using anti-obesity drugs

MRG's new report on neurovascular embolectomy device market

MRG's new report on neurovascular embolectomy device market

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

Knopp Neurosciences to accelerate the development of KNS-760704 in ALS, says CEO of Knopp

Knopp Neurosciences to accelerate the development of KNS-760704 in ALS, says CEO of Knopp

Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan

Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan

Adult stem cell treatments for severe limb ischemia and refractory coronary ischemia discussed

Adult stem cell treatments for severe limb ischemia and refractory coronary ischemia discussed

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.